Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04323761 |
|---|---|
| Brief Title: | Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) |
| First Submitted : | March 24, 2020 |
| First Submitted that Met QC Criteria : | March 24, 2020 |
| First Posted : | March 27, 2020 |
| Last Update Submitted that Met QC Criteria : | November 10, 2020 |
| Last Update Posted : | November 13, 2020 |